UK markets closed

JNJ Sep 2020 60.000 put

OPR - OPR Delayed price. Currency in USD
Add to watchlist
0.02000.0000 (0.00%)
As of 9:30AM EDT. Market open.
Full screen
Previous close0.0200
Open0.0200
Bid0.0000
Ask0.1200
Strike60.00
Expiry date2020-09-18
Day's range0.0200 - 0.0200
Contract rangeN/A
Volume30
Open interest102
  • Coronavirus update: Johnson & Johnson vaccine enters phase 3 as Fauci heads to Senate
    Editor's pick
    Yahoo Finance

    Coronavirus update: Johnson & Johnson vaccine enters phase 3 as Fauci heads to Senate

    Johnson & Johnson announced that its coronavirus vaccine candidate had entered the pivotal human trial phase that will enroll up to 60,000 participants worldwide.

  • Why Vaxart Stock Is Retreating Today
    Motley Fool

    Why Vaxart Stock Is Retreating Today

    Johnson & Johnson's rapid progress on its coronavirus vaccine is weighing on the biotech's shares today.

  • J&J kicks off study of single-shot COVID-19 vaccine in 60,000 volunteers
    Reuters

    J&J kicks off study of single-shot COVID-19 vaccine in 60,000 volunteers

    Johnson & Johnson <JNJ.N> on Wednesday began a 60,000-person trial of an experimental single-shot COVID-19 vaccine that, if proven effective, could simplify distribution of millions of doses compared with leading rivals requiring two doses. The company expects results of the Phase III trial by year end or early next year, Dr. Paul Stoffels, J&J's chief scientific officer, said in a joint news conference with officials from the National Institutes of Health and the Trump administration. J&J plans to manufacture as many as 1 billion doses in 2021, and more after that, Stoffels said.

By using Yahoo, you agree that we and our partners can use cookies for purposes such as customising content and advertising. See our Privacy Policy to learn more